Literature DB >> 3466642

The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia. III. Evaluation of cell size by morphology and volume measurements.

J V Melo, J Wardle, M Chetty, J England, S M Lewis, D A Galton, D Catovsky.   

Abstract

The peripheral blood WBC size distribution was assessed by morphological and volume measurements in 73 patients with B-cell chronic lymphocytic leukaemia (CLL) and prolymphocytic leukaemia (PLL). Patients with typical CLL, with less than or equal to 10% prolymphocytes, had a homogeneous major population of small cells which could be recognized both by morphology and volume (median volume 211.5 +/- 32.5 fl). In PLL, the volume of the main cell component was significantly larger than in CLL: in two-thirds of cases the major cell population was distributed in a first lognormal fitted curve of the volume histogram, with median volume 281.8 +/- 38.0 fl; in the remaining cases the main cell component showed a larger median volume (353.5 +/- 71.9 fl) contained within the second lognormal curve which was preceded by a minor peak. CLL patients with 11-55% prolymphocytes (CLL/PL) had characteristic cell volume histograms in which two lognormal curves could always be fitted: in 80% of cases the main cell component was located in a first curve with median volume of 257.9 +/- 28.6 fl; in the remaining cases the major population was represented by cells with median volume of 349.0 +/- 83.9 fl distributed in a second peak. Although in both CLL and CLL/PL the majority of cells was defined morphologically as small, the median volume of these lymphocytes was significantly larger in CLL/PL. The degree of concordance in the assessment of cell size between morphology and volume measurements was high in CLL, whereas in CLL/PL and PLL morphology underestimated the cell size of the major population, compared with its actual volume, in over 50% of cases. We conclude that the identification of prolymphocytes as larger cells in blood films may be hampered by distortions and artefacts of spreading. Volume measurements may provide a more objective indicator of the cell populations in this group of disorders.

Entities:  

Mesh:

Year:  1986        PMID: 3466642     DOI: 10.1111/j.1365-2141.1986.tb02202.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  5 in total

1.  The role of cell maturation in the generation of phenotypic heterogeneity in B-cell chronic lymphocytic leukaemia.

Authors:  A H Maddy; A Sanderson; M J Mackie; S K Smith
Journal:  Immunology       Date:  1989-11       Impact factor: 7.397

2.  Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group.

Authors:  J M Bennett; D Catovsky; M T Daniel; G Flandrin; D A Galton; H R Gralnick; C Sultan
Journal:  J Clin Pathol       Date:  1989-06       Impact factor: 3.411

Review 3.  Management of chronic lymphocytic leukaemia.

Authors:  N Kalil; B D Cheson
Journal:  Drugs Aging       Date:  2000-01       Impact factor: 3.923

4.  A rare case of B-lymphoproliferative disorder with villous lymphocytes harboring t(8;14)(q24;q32) translocation.

Authors:  Xiaofeng Shi; Rong Ba; Haiyan You; Qian Jiang; Jiansong Huang; Jianhua Mao; Lanxiu Han; Shuo Zhang; Qin Zhuang; Xianqiu Yu; Lixia Wang; Yun Wang; Dongya Li; Wei Zhu; Yong Zhang; Yan Zhu; Xiaodong Xi
Journal:  Front Med       Date:  2017-10-27       Impact factor: 4.592

5.  Cell sizing in chronic lymphoproliferative disorders: an aid to differential diagnosis.

Authors:  H D Alexander; G M Markey; R L Nolan; T C Morris
Journal:  J Clin Pathol       Date:  1992-10       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.